Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
COWZ vs XBI: how they differ
COWZ and XBI hold 3% of their weight in the same names, and XBI returned more over the year.
Pacer US Cash Cows 100 ETF and State Street(R) SPDR(R) S&P(R) Biotech ETF.
What they hold in common
By the books each fund has filed, COWZ and XBI hold 3% of their money in the same securities at the same weight.
| Holding | COWZ | XBI |
|---|---|---|
| Gilead Sciences Inc | 1.84% | 0.97% |
| Regeneron Pharmaceuticals Inc | 1.17% | 0.96% |
| Biogen Inc | 0.67% | 1.03% |
| Incyte Corp | 0.44% | 1.00% |
| United Therapeutics Corp | 0.41% | 0.93% |
| Only in COWZ | Only in XBI |
|---|---|
| QUALCOMM Inc 2.67% | Apogee Therapeutics Inc 1.49% |
| Altria Group Inc 2.21% | Moderna Inc 1.41% |
| ConocoPhillips 2.17% | Twist Bioscience Corp 1.41% |
| CVS Health Corp 2.16% | Oruka Therapeutics Inc 1.38% |
| Bristol-Myers Squibb Co 2.03% | Kymera Therapeutics Inc 1.36% |
| Ford Motor Co 2.01% | Viking Therapeutics Inc 1.31% |
| Uber Technologies Inc 2.01% | Praxis Precision Medicines Inc 1.29% |
| Pfizer Inc 2.00% | Erasca Inc 1.27% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.
| COWZ Pacer US Cash Cows 100 ETF | XBI State Street(R) SPDR(R) S&P(R) Biotech ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | Pacer | State Street |
| What it is | US Cash Cows 100 | SPDR S&P Biotech |
| Total return, 1 year | +23.4% | +64.0% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +5.9 pts | +46.5 pts |
| Expense ratio | 0.49% | 0.35% |
| Already in the S&P 500 | 95.8% | 8.5% |
| Holdings | 100 | 150 |
COWZ in plain words
COWZ is an index equity fund tracking the US Cash Cows 100. Over the year to Sep 11, 2026 it returned +23.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.49% a year. By its holdings filed for Apr 30, 2026, 96% of the fund by weight is stocks the S&P 500 also holds, across 100 positions, with the top ten at 21.2%. It sat 3.2% below its high of Sep 3, 2026 on Sep 11, 2026.
XBI in plain words
XBI is an index equity fund tracking the SPDR S&P Biotech. Over the year to Sep 11, 2026 it returned +64.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.35% a year. By its holdings filed for Jun 30, 2026, 8% of the fund by weight is stocks the S&P 500 also holds, across 150 positions, with the top ten at 13.3%. It sat 9.6% below its high of Feb 8, 2021 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, COWZ or XBI?
- In the year to Sep 12, 2026, with distributions reinvested, COWZ returned +23.4% and XBI returned +64.0%, so XBI returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, COWZ or XBI?
- COWZ charges 0.49% a year and XBI charges 0.35%, so XBI is cheaper. Fees come from each fund's prospectus.
- How much do COWZ and XBI overlap with the S&P 500?
- By their latest filed holdings, 96% of COWZ and 8% of XBI by weight is stocks the S&P 500 already holds. Between the two funds, 3% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, COWZ against XBI, data as of Sep 12, 2026. https://etfiq.com/compare/any/COWZ-XBI Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources